Predictors of Mortality in Pediatric Acute Lymphoblastic Leukemia: Analysis of 1004 Cases
DOI:
https://doi.org/10.35845/abms.2023.1.273Keywords:
mortality, pediatric, acute lymphoblastic leukemiaAbstract
Objective: To assess the predictors of treatment-related mortality (TRM) among pediatric acute lymphoblastic leukemia (ALL) cases in Pakistan.
Methodology: This retrospective study was conducted in the Pediatric Oncology department at Combined Military Hospital Rawalpindi, Pakistan. All newly diagnosed ALL cases between the ages of one and 18 years from 1st January 2013, to 31st December 2022 were included in the study. Physical and demographic data of all subjects were obtained and treatment outcome in terms of any complications or mortality were recorded during the above mentioned period. All data were analyzed using SPSS software.
Results: Among 1004 cases of ALL 636(63.3%) were males and 368(36.7%) were females. The mean age during the diagnosis was 5.76±3.60 years. Overall Mortality was 295 (29.4%) including 191/295(64.7%) TRM and 104(35.3%) relapse-related mortality. Among the TRM cases, 124/191(64.9%) expired during induction. The usual complication during induction was Neutropenic fever. In univariate analysis, malnutrition (P=0.043), high WBC count (P=0.011), reduced hemoglobin level (P=0.005), low platelet count (P=0.002), neutropenic sepsis (P=0.001), and hepatotoxicity (P=0.001), were found to be related to high induction mortality. On multivariate analysis, infection was the most significant predictor of mortality during the induction and post-induction period. Infection followed by bleeding was the most common cause of mortality. After a median follow-up of 49.94+34.04 months, the overall Survival and Disease-Free Survival rates at five years were 70.6% and 68.4% respectively.
Conclusion. The main causes of TRM in pediatric ALL are Neutropenic fever and bleeding. Malnutrition, high WBC count, neutropenic sepsis, and hepatotoxicity are the main predictors of high TRM.
Key Words: Pediatric, Acute Lymphoblastic Leukemia, Mortality, Treatment Related Mortailty
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anwar Ullah, Tariq Ghafoor, Ishfaq Ahmad, Shakeel Ahmad, Awais Arshad

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may Share-copy and redistribute the material in any medium or format and Adapt-remix, transform, and build upon the material. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

. 


